0001593968-24-001088.txt : 20240820 0001593968-24-001088.hdr.sgml : 20240820 20240820170620 ACCESSION NUMBER: 0001593968-24-001088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240816 FILED AS OF DATE: 20240820 DATE AS OF CHANGE: 20240820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly James Patrick CENTRAL INDEX KEY: 0001506314 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 241226077 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 QUINCE ORCHARD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 700 QUINCE ORCHARD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 primary_01.xml PRIMARY DOCUMENT X0508 4 2024-08-16 0001000694 NOVAVAX INC NVAX 0001506314 Kelly James Patrick 700 QUINCE ORCHARD ROAD GAITHERSBURG 20878 true EVP, CFO and Treasurer false Common Stock 2024-08-16 4 M false 2367 12.96 A 15652 D Common Stock 2024-08-16 4 F false 1223 12.96 D 14429 D Restricted Stock Units 0 2024-08-16 4 M false 2367 0 D 2031-08-16 Common Stock 2367 0 D One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date. /s/Mark J. Casey, Attorney-in-Fact 2024-08-20